Rapid and Direct AAV Capsid Quantitation
Adeno-associated virus (AAV) technology has become a crucial method for delivering gene therapy drugs and vaccines. The quantitation of viral capsids enables researchers to ensure that AAV preparations are of high quality and potency. However, challenges remain with the accurate quantitation and detection of multiple AAV serotypes.
By improving quantitation and developing rapid, highly sensitive techniques. Researchers can overcome these challenges and expedite their AAV bioprocessing workflows to deliver vital new drugs to market.
Download this application note to discover:
- Optimized assay workflows for label-free AAV detection
- High-throughput titer analysis methods that mitigate unwanted matrix effects
- The latest high-specificity solutions for the quantitation of a broad range of serotypes